Interleukin-13 neutralization modulates interleukin-13 induced suppression of reactive oxygen species production in peritoneal macrophages in a murine T-cell lymphoma

Cellular Immunology

Volumn 251, Issue 2, 2008, Pages 72-77

  Deepak, Praveen ^a   Kumar, Sanjay ^a   Acharya, Arbind ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Dalton's lymphoma; IL 13 neutralization; Interleukin 13; Macrophages; Reactive oxygen intermediates; Tumor associated macrophages

Indexed keywords

CHEMOKINE; INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR ALPHA2; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; IMMUNE RESPONSE; IN VIVO STUDY; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T CELL LYMPHOMA; TH2 CELL; TUMOR IMMUNITY;

ANIMALS; ANTIBODIES, MONOCLONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HYDROGEN PEROXIDE; INTERFERON TYPE II; INTERLEUKIN-13; INTERLEUKIN-13 RECEPTOR ALPHA1 SUBUNIT; LIPOPOLYSACCHARIDES; LYMPHOMA, T-CELL; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED BALB C; REACTIVE OXYGEN SPECIES; RECOMBINANT PROTEINS; SPECIFIC PATHOGEN-FREE ORGANISMS;

MURINAE; MUS;

EID: 47249137341     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2008.03.005     Document Type: Article

References (39)

1. Brown K.D., Zurawski S.M., Mosmann T.R., and Zurawski G. A family of small inducible proteins secreted by lymphocytes is members of new super family that induces leukocytes and fibroblast-derived inflammatory agents, growth factors and indicators of various activation processes. J. Immunol. 142 (1989) 679-687
2. + T-cells: modulation by interleukin-4 and interleukin-12. Eur. J. Immunol. 26 (1996) 571-577
3. Terabe M., Matsui S., Noben-Trauth N., Chen H., Watson C., Donaldson D.D., Carbone D.P., Paul W.E., and Berzofsky J.A. NKT-cell mediated repression of tumor-immunosurveillance by IL-13 and IL-4R-STAT 6 pathway. Nature 1 (2000) 515-520
4. van der Pauw Kraan T.C.T.M., Boeiji L.C.M., Troon J.T.M., Rutschmann S.K., Wijdenes J., and Aarden L.A. Human IL-13 production is negatively influenced by CD3 engagement. J. Immunol. 156 (1996) 1818-1823
5. Doherty T.M., Kastelein R., Menon S., Andrade S., and Coffman R.L. Modulation of murine macrophage function by IL-13. J. Immunol. 151 (1993) 7151-7160
6. Deepak P., Kumar S., and Acharya A. IL-13 neutralization modulates function of type II polarized macrophages in vivo in a murine T-cell lymphoma. Eur. J. Inflammation 5 (2007) 37-45
7. de Waal Malefyt R., Figdor C.G., Huijbens R., Mohan-Peterson S., Bennett B., Culpepper J., Dang W., Zurawski G., and de Vries J.E. Effects of IL-13 on phenotype, cytokine production and cytotoxic function of human monocytes: comparison with IL-4 and modulation by IFN-γ or IL-10. J. Immunol. 151 (1993) 6370-6381
8. Bonecchi R., Sozzani S., Stine J.T., Luini W., D'Amico G., Allavena P., Chantry D., and Mantovani A. Divergent effects of interleukin-4 and interferon-g on macrophage-derived chemokine production: an amplification circuit of T-helper 2 responses. Blood 92 (1998) 2668-2671
9. Andrew D.P., Chang M.-S., McNinch J., Wathen S.T., Rihanek M., Tseng J., Spellberg J.P., and Elias C.G. STCP-1 CMDC1 CC-chemokine acts specifically on chronically activated Th2 lymphocytes and is produced by monocytes on stimulation with Th2 cytokines IL-4 and IL-13. J. Immunol. 161 (1998) 5027-5038
10. van den Berg A., Visser L., and Poppema S. High expression of CC-chemokine TARC in Reed-Sternberg cells: a possible explanation for the characteristic T-cell infiltration in Hodgkin's lymphoma. Am. J. Pathol. 154 (1999) 1685-1691
11. Manna S.K., and Aggrawal B.B. IL-13 suppresses TNF-induced activation of nuclear factor-κB, activation protein-1 and apoptosis. J. Immunol. 161 (1998) 2863-2872
12. Deepak P., Kumar S., and Acharya A. Interleukin-13-induced type II polarization of inflammatory macrophages is mediated through suppression of nuclear factor-κB and preservation of IκBα in a T-cell lymphoma. Clin. Exp. Immunol. 2 (2007) 378-386
13. Mantovani A., Allavena P., and Sica A. Tumor-associated macrophages as a prototypic type II polarized phagocytic population: role in tumor progression. Eur. J. Cancer 40 (2004) 660-1667
14. Miller R.A., and Britigan B.E. Role of oxidants in microbial pathophysiology. Clin. Microbiol. Rev. 10 (1997) 1-18
15. Sozzani P., Cambon C., Vita N., Séguélas M.-H., Caput D., Ferrara P., and Pipy B. Interleukin-13 inhibits protein kinase C-triggered respiratory burst in human monocytes, Role of calcium and cyclic AMP. J. Biol. Chem. 270 (1995) 5084-5088
16. Sozzani P., Hasan L., Séguélas M.-H., Caput D., Ferrara P., Pipy B., and Cambon C. IL-13 induces tyrosine phosphorylation of phospholipases Cγ-1 following IRS-2 association in human monocytes: relationship with the inhibitory effect of IL-13 on ROI production. Biochem. Biophys. Res. Commun. 244 (1998) 665-670
17. Canaway R., Lanman D.F., Leeman J.B., Leeman S.E., Paterson B.M., and Weich H.J. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. J. Physiol. 323 (1982) 403-407
18. Ding A.H., Nathan C.F., and Stueter D.J. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophage. Comparison of activating cytokines and evidence for independent production. J. Immunol. 141 (1988) 2407-2412
19. Mae Micking J., Xie Q.W., and Nathan C. Nitric oxide and macrophage function. Ann. Rev. Immunol. 15 (1997) 323-350
20. Fidler I.J., and Schroit A.J. Recognition and destruction of neoplastic cells by activated macrophages: discrimination of altered self. Biochim. Biophys. Acta 948 (1988) 151-173
21. Gordon S. Alternative activation of macrophages. Nat. Rev. Immunol. 3 (2003) 23-35
22. Mosser D.M. The many faces of macrophage activation. J. Leukoc. Biol. 73 (2003) 209-212
23. Pollard J.W. Tumor-educated macrophages promote tumor progression and metastasis. Nat. Rev. Cancer 4 (2004) 71-78
24. Klimp A.H., Hollema H., Kempinga C., van der Zee A.G.J., de Vries E.G.E., and Daemen T. Expression of cyclo-oxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages. Cancer Res. 61 (2001) 7305-7309
25. Sica A., Saccani A., Bottazzi B., Polentarutti N., Vecchi A., Damme J.V., and Mantovani A. Autocrine production of IL-10 mediates defective IL-12 production and NF-κB activation in tumor-associated macrophages. J. Immunol. 164 (2000) 762-767
26. Singh M.P., Rai A.K., and Singh S.M. Gender dimorphism in the progressive in vivo growth of a T-cell lymphoma: involvement of cytokines and gonadal hormones. J. Reprod. Immunol. 65 (2005) 17-32
27. 2+ and protein kinase C. Int. J. Immunopharmacol. 19 (1997) 129-133
28. Parajuli P., and Singh S.M. Modulation of hematopoiesis in normal and tumor-bearing mice on in vivo administration of FK565. J. Immunopathol. Pharmacol. 8 (1995) 103-111
29. Parajuli P., and Singh S.M. Alteration in IL-1 and arginase activity of tumor-associated macrophages: a role in the promotion of tumor growth. Cancer Lett. 107 (1996) 249-256
30. Parajuli P., Singh S.M., Kumar A., and Sodhi A. Alteration in the tumoricidal functions of murine tumor-associated macrophage during progressive growth of a tumor in vivo. Cancer J. 10 (1997) 220-227
31. Bharti A., and Singh S.M. Inhibition of macrophage nitric oxide production by gangliosides derived from a spontaneous T-cell lymphoma: the involved mechanism. Nitric Oxide 8 (2003) 75-82
32. Shanker A., Singh S.M., and Sodhi A. Ascitic growth of a spontaneous T-cell lymphoma induces thymic involution. 1. Alteration in the CD4/CD8 distribution in thymocytes. Tumor Biol. 21 (2000) 288-298
33. Shanker A., Singh S.M., and Sodhi A. Ascitic growth of a spontaneous transplantable T-cell lymphoma induces thymic involution. 2. Induction of apoptosis in thymocytes. Tumor Biol. 21 (2000) 315-327
34. Ma J., Chen T., Mandelin J., Ceponis A., Miller N.E., Hukkanen M., Ma G.F., and Konttinen Y.T. Regulation of macrophage activation. Cell. Mol. Life Sci. 60 (2003) 2334-2346
35. Baj-Krzyworzeka M., Baran J., Szatanek R., Stankiewiez D., Siedler M., and Zembala M. Prevention and reversal of tumor cell-induced monocyte deactivation by cytokines, purified protein derivative (PPD), and anti-IL-10 antibody. Cancer Immun. 4 (2004) 8-19
36. Gratchev A., Kzhyshkowska J., Köthe K., Muller-Molinet I., Kannookadan S., Utikal J., and Goerdt S. MΦ1 and MΦ2 can be re-polarized by Th2 or Th1 cytokines, respectively, and respond to exogenous danger signal. Immunobiology 211 (2006) 473-486
37. Nakamura S. World Health Organization (WHO) classification of malignant lymphoma-how is the WHO now?. Gan to Kagaku ryoho 31 (2004) 149-157
38. Moll A., Niwald A., Gratek M., and Stolarska M. Ocular complications in leukemia and malignant lymphoma in children. Klin. Oczna 106 (2004) 783-787
39. Zhou J., Mauere K., Farina L., and Gribben J.G. The role of the tumor microenvironment in hematological malignancies and implication for therapy. Front Biosci. 10 (2005) 1581-1596